F. Knutson, J. Osselaer, L. Pierelli
May 15, 2015
Citations
0
Influential Citations
74
Citations
Quality indicators
Journal
Vox Sanguinis
Abstract
A photochemical treatment process (PCT) utilizing amotosalen and UVA light (INTERCEPT™ Blood System) has been developed for inactivation of viruses, bacteria, parasites and leucocytes that can contaminate blood components intended for transfusion. The objective of this study was to further characterize the safety profile of INTERCEPT‐treated platelet components (PCT‐PLT) administered across a broad patient population.